Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients

被引:0
|
作者
Kenichi Namba
Toshikatsu Kaburaki
Hidekazu Tsuruga
Yohei Ogawa
Eri Iwashita
Hiroshi Goto
机构
[1] Hokkaido University,Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine
[2] University of Tokyo School of Medicine,Department of Ophthalmology
[3] Jichi Medical University Saitama Medical Center,Department of Ophthalmology
[4] AbbVie GK,Department of Ophthalmology
[5] Tokyo Medical University,undefined
来源
Ophthalmology and Therapy | 2022年 / 11卷
关键词
Adalimumab; Behçet’s Disease; Sarcoidosis; Uveitis; Vogt-Koyanagi-Harada Disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1147 / 1161
页数:14
相关论文
共 50 条
  • [21] Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan
    Yamada, Miyuki
    Suzuki, Katsuyoshi
    Matsui, Daisuke
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2021, 170
  • [22] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice ― A Post-Marketing Surveillance ―
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2024, 88 (02) : 263
  • [23] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice - A Post-Marketing Surveillance -
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2021, 85 (12) : 2201 - +
  • [24] Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance
    Uhara, Hisashi
    Tsuchida, Tetsuya
    Kiyohara, Yoshio
    Akamatsu, Ayumi
    Sakamoto, Takahiko
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : 862 - 871
  • [25] Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study
    Ohtsuki, Mamitaro
    Okubo, Yukari
    Saeki, Hidehisa
    Igarashi, Atsuyuki
    Imafuku, Shinichi
    Abe, Masatoshi
    Chaudhari, Siddharth
    Yaguchi, Masafumi
    Emoto, Ayumi
    Morita, Akimichi
    JOURNAL OF DERMATOLOGY, 2024, 51 (07): : 950 - 963
  • [26] Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data
    Yamazaki, Hiroyoshi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Tajima, Koyuki
    Murakami, Masahiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 963 - 971
  • [27] Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study
    Suhler, Eric B.
    Jaffe, Glenn J.
    Nguyen, Quan Dong
    Brezin, Antoine P.
    Zierhut, Manfred
    Vitale, Albert
    van Velthoven, Mirjam
    Adan, Alfredo
    Lim, Lyndell
    Kramer, Michal
    Schlaen, Ariel
    Fortin, Eric
    Muccioli, Cristina
    Goto, Hiroshi
    Kaburaki, Toshikatsu
    Camez, Anne
    Song, Alexandra P.
    Kron, Martina
    Tari, Samir
    Dick, Andrew D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Kawai, Shinichi
    Yamamoto, Kazuhiko
    Harigai, Masayoshi
    Ishida, Kota
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 8 - 16
  • [29] Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma: A Post-marketing Surveillance Study
    Kaneko, Fumiya
    Suzuka, Hiroshi
    Yoshino, Tomoaki
    Hinosugi, Ryosuke
    INTERNAL MEDICINE, 2024, 63 (22) : 3039 - 3048
  • [30] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Hasebe, Miki
    Fukamizu, Yuji
    Rodrigues, Ema
    Utsugisawa, Kimiaki
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14